Company profile: AiCure
1.1 - Company Overview
Company description
- Provider of AI-driven data analytics to understand patient response to treatments, offering a regulatory-compliant platform to capture and analyze digital biomarkers for predicting participant behavior and treatment response, a Patient Connect mobile app with computer vision for real-time dosing guidance and adherence, site services supporting clinical operations and engagement, and OpenDBM for open-source access to digital biomarker algorithms.
Products and services
- AiCure Platform: A regulatory-compliant AI system that captures and analyzes digital biomarkers to forecast participant behavior and treatment response across trials
- AiCure Patient Connect: A computer-vision–enabled mobile product that delivers real-time dosing instructions and verifies medication adherence for clinical trial participants
- AiCure Site Services: A clinical-operations–focused service that eases site technology burdens and offers direct access to AiCure experts to strengthen patient engagement
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AiCure
PMOD Technologies
HQ: Switzerland
Website
- Description: Provider of software quantification tools for biomedical imaging in humans and animals. PMOD software originated in 1993, developed at the University Hospital PET Center in Zurich when PET was mainly a research tool, and was adopted by the PET community.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PMOD Technologies company profile →
InCrowd
HQ: United States
Website
- Description: Provider of a market research platform for life sciences companies to obtain real-time feedback from healthcare professionals. Offerings include MicroSurvey for short, real-time surveys; MicroTracker and Essentials for wave-over-wave tracking; InCrowd Interview for automated qualitative research; and Access/Access+ to a global panel of healthcare professionals and patients with survey support and optimization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InCrowd company profile →
Aperio
HQ: United States
Website
- Description: Provider of digital pathology solutions for hospitals, reference labs, and pharmaceutical and research institutions across the world, offering an affordable, complete portfolio that enhances quality assurance, delivers more efficient workflows, and improves patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aperio company profile →
Liquid Biosciences
HQ: United States
Website
- Description: Provider of a bio-analytics platform supporting healthcare projects and collaborations with biopharma, diagnostic, clinical research, and academic institutions; biomarker discovery to aid diagnostics and therapeutic development; and drug rescue and development acceleration services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liquid Biosciences company profile →
Consensus
HQ: United States
Website
- Description: Provider of an AI-powered search engine that finds answers in scientific research, enabling discovery and consumption of the world's expert knowledge.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Consensus company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AiCure
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AiCure
2.2 - Growth funds investing in similar companies to AiCure
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AiCure
4.2 - Public trading comparable groups for AiCure
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →